Publications by authors named "Clark Paramore"

Claim this Profile
C
Cost-Effectiveness of Lovotibeglogene Autotemcel (Lovo-Cel) Gene Therapy for Patients with Sickle Cell Disease and Recurrent Vaso-Occlusive Events in the United States.
William L Herring, Meghan E Gallagher, Nirmish Shah, K C Morse, Deirdre Mladsi, Clark Paramore

Pharmacoeconomics· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine management, healthcare resource use and patient and carer-reported outcomes of patients with transfusion-dependent β-thalassaemia in the United Kingdom: A mixed methods observational study.
Farrukh Shah, Paul Telfer, Mark Velangi, Shivan Pancham, Robert Wynn, Clark Paramore

EJHaem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia.
Anuraag R Kansal, Odette S Reifsnider, Sarah B Brand, Neil Hawkins, Anna Coughlan, Clark Paramore

J Mark Access Health Policy· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient- and Caregiver-Reported Burden of Transfusion-Dependent β-Thalassemia Measured Using a Digital Application.
Clark Paramore, Laurice Levine, Emma Bagshaw, Chengyu Ouyang, Amber Kudlac

Patient· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.
Minesh Jobanputra, Clark Paramore, Sandra G Laird, Michael McGahan, Paul Telfer

Br J Haematol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health state utilities associated with treatment for transfusion-dependent β-thalassemia.
Louis S Matza, L Clark Paramore, Katie D Stewart, Hayley Karn, Minesh Jobanputra

Eur J Health Econ· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Literature Review of the Burden of Disease and Treatment for Transfusion-dependent β-Thalassemia.
Marissa Betts, Patrick A Flight, L Clark Paramore, Li Tian, Dušan Milenković

Clin Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodone.
Rami Ben-Joseph, Jill A Bell, Abhishek Chitnis, Anuraag Kansal, Pamela Holly, Clark Paramore

J Med Econ· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Early Engagement Model in Product Development: Linking "Proof of Concept" to "Proof of Medical Value".
Sheikh Usman Iqbal, Tehseen Salimi, John Dunlop, L Clark Paramore

Ther Innov Regul Sci· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone.
Rami Ben-Joseph, Jill A Bell, Diana Brixner, Anuraag Kansal, Clark Paramore

J Manag Care Spec Pharm· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States.
Marissa Blieden, L Clark Paramore, Dhvani Shah, Rami Ben-Joseph

Expert Rev Clin Pharmacol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient RSV lower respiratory infections among high-risk infants and other pediatric populations.
L Clark Paramore, Parthiv J Mahadevia, Pedro A Piedra

Pediatr Pulmonol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of biologic therapy: a forecasting model in three disease areas.
L Clark Paramore, Craig A Hunter, Bryan R Luce, Robert J Nordyke, R J Halbert

Curr Med Res Opin· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of resource utilization and cost burden before and after an employer-based migraine education program.
Matthew J Page, L Clark Paramore, Dilesh Doshi, Marcia F T Rupnow

J Occup Environ Med· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002.
Russell Cohen, Don Robinson, Clark Paramore, Kathy Fraeman, Kevin Renahan

Inflamm Bowel Dis· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic sclerosis prevalence and comorbidities in the US, 2001-2002.
Don Robinson, Debra Eisenberg, Paul J Nietert, Mittie Doyle, Mohan Bala, Clark Paramore

Curr Med Res Opin· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can managed care organizations partner with manufacturers for comparative effectiveness research?
Bryan R Luce, L Clark Paramore, Bhash Parasuraman, Bengt Liljas, Gregory de Lissovoy

Am J Manag Care· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
Chenglong Han, Don W Robinson, Monica V Hackett, L Clark Paramore, Kathy H Fraeman

J Rheumatol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.
Karin S Coyne, Clark Paramore, Susan Grandy, Marco Mercader, Matthew Reynolds

Value Health· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The return on investment in health care: from 1980 to 2000.
Bryan R Luce, Josephine Mauskopf, Frank A Sloan, Jan Ostermann, L Clark Paramore

Value Health· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of illness of hyponatremia in the United States.
Audra Boscoe, Clark Paramore, Joseph G Verbalis

Cost Eff Resour Alloc· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer.
L Clark Paramore, Simu K Thomas, Kevin B Knopf, Lael S Cragin, Kathy H Fraeman

Clin Colorectal Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incorporating pharmacoeconomic and health outcomes into randomized clinical trials.
Dennis A Revicki, Clark Paramore, Anne M Rentz

Expert Rev Pharmacoecon Outcomes Res· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient satisfaction with budesonide Turbuhaler versus triamcinolone acetonide administered via pressurized metered-dose inhaler in a managed care setting.
Kevin B Weiss, L Clark Paramore, Bengt Liljas, Dennis A Revicki, Bryan R Luce

J Asthma· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A review of the economic burden of ADHD.
Louis S Matza, Clark Paramore, Manishi Prasad

Cost Eff Resour Alloc· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis